USFDA completes inspection at facility of Granules India’s arm

22 Aug 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspection of the facility of Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals, Inc., US on August 21, 2019 with two minor observations.

This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

585.75 13.85 (2.42%)
18-Mar-2026 15:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1780.00
Dr. Reddys Lab 1287.00
Cipla 1268.20
Zydus Lifesciences 901.00
Lupin 2295.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×